Monthly Prescribing Reference

FreeStyle Libre 2 Cleared for Use in Adults and Pediatric Patients With Diabetes

The FDA has approved the FreeStyle® Libre 2 integrated continuous glucose monitoring system (Abbott) for adults and children ≥4 years of age with diabetes. The Food and Drug Administration (FDA) has ...
Pharmabiz

Ambrosia introduces new version of NightRider BluCon to work with FreeStyle Libre 2 sensor & "Direct-to-Apple watch"

Ambrosia Systems, a fast growing medical technology company, announced the launch of the next version of NightRider BluCon to work with FreeStyle Libre 2 sensor. The new NightRider BluCon also works ...
Nasdaq

Tandem Diabetes Care’s t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre® 2 Plus Sensor

Abbott’s latest innovation, the FreeStyle Libre® 2 Plus sensor, is available for the first time for t:slim X2™ insulin pump users in the U.S. Tandem’s Control-IQ™ hybrid closed-loop technology now ...
Healio

Standalone reader for FreeStyle Libre 3 CGM receives FDA clearance

The FDA granted clearance for a standalone reader to be used for glucose management with the FreeStyle Libre 3 CGM. Users will have the option to use either the reader or the device’s smartphone app.
FierceBiotech

Abbott's slimmed-down FreeStyle Libre glucose sensor notches FDA nod

Nearly two years after going live in Europe, the latest version of Abbott’s FreeStyle Libre continuous glucose monitor is ready to make its stateside debut. The FDA cleared the FreeStyle Libre 3 ...